Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 28;6(2):270-284.
doi: 10.1093/ehjdh/ztaf005. eCollection 2025 Mar.

Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review

Affiliations
Review

Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review

Ruben G A van der Waerden et al. Eur Heart J Digit Health. .

Abstract

Intracoronary optical coherence tomography (OCT) is a valuable tool for, among others, periprocedural guidance of percutaneous coronary revascularization and the assessment of stent failure. However, manual OCT image interpretation is challenging and time-consuming, which limits widespread clinical adoption. Automated analysis of OCT frames using artificial intelligence (AI) offers a potential solution. For example, AI can be employed for automated OCT image interpretation, plaque quantification, and clinical event prediction. Many AI models for these purposes have been proposed in recent years. However, these models have not been systematically evaluated in terms of model characteristics, performances, and bias. We performed a systematic review of AI models developed for OCT analysis to evaluate the trends and performances, including a systematic evaluation of potential sources of bias in model development and evaluation.

Keywords: Artificial intelligence; Coronary; Deep learning; Intravascular imaging; Optical coherence tomography; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: G.W.S. declares grants from Shockwave, Biosense-Webster, Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave, and PCORI (via Weill Cornell Medical Center); consulting fees from Cardiomech, Robocath, Daiichi Sankyo, Vectorious, Miracor, Apollo Therapeutics, Abbott, Cardiac Success, Occlutech, Millennia Biopharma, Remote Cardiac Enablement, Ablative Solutions, Valfix, Zoll, HeartFlow, Shockwave, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, and Aria; speaker fee from Pulnovo, Medtronic, Amgen, Boehringer Ingelheim, and Abiomed; stocks for Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, and Xenter. N.H. declares grants from Abbott, Biosensors, Boston Scientific, and Medis Medical Imaging; speaker fee from Abbott and Teruma. E.K. declares grants from Abbott and Medtronic; speaker fee from Abbott; stocks for Electroducer and V3. J.E. declares speaker fee from Abbott. D.P. declares speaker fee from Abbott and GE Healthcare. G.G. declares grants from Abbott; consulting fees from Abbott, Infraredx, Panorama Scientific, Gentuity, InnovaHTS, and Terra Quantum; speaker fee from GE Medical, Nipro, and Abbott; payment for expert testimony from ConneX Biomedical; support for attending meetings from Abbott. S.M. declares grants from Abbott; consulting fees from NovoNordisk, Amgen, and Johnson and Johnson; participation on an advisory board in MK-0616 Coral Reef outcomes. N.P.-E. declares grants from Abbott Vascular; consulting fees from Abbott Vascular and Philips; speaker fee from Abbott Vascular, Philips, SIS Medical, and Novartis. R.M. declares consulting fees from Abbott Vascular, Boston Scientific, and Medtronic Inc.; speaker fee from Boston Scientific, Bayer, Daiichi Sankyo, Meril, Edwards LifeSciences, AMGEN, Biotronik, Biosensors, Abbott Vascular, Braun, and Philips. L.R. declares grants from Abbott, Boston Scientific, Biotronik, Infraredx, Sanofi, and Regeneron; consulting fees from Abbott, Canon, Gentuity, Medtronic, NovoNordisc, Occlutech, and Sanofi. B.v.G. declares stocks for Thirona. C.I.S. declares grants from Novartis and Boehringer Ingelheim; speaker fee from Novartis and Bayer. I.I. declares grants or contracts from Pie Medical Imaging BV, Esaote SpA, Dutch Science Foundation with participation of Philips Healthcare, Pie Medical Imaging, GE, Abbott, Heu, and IHI; support for attending meetings from SCCT; patents planned, issued, or pending from US patent 10,176,575; 10,395,366; 11,004,198; 10,699,407; and from US App. Patent US17/317,746; US16/911,323; US18/206,536. N.v.R. declares grants from Koninklijke Philips NV, Biotronik, Medtronic Inc, Abbott; speaker fee from MicroPort, Bayer AG, and RainMed Medical.

Figures

Graphical Abstract
Graphical Abstract
Systematic review on artificial intelligence (AI) tasks in intracoronary optical coherence tomography (OCT): performance and bias signalling. Left panel: Typical tasks for AI for the automated assessment of intracoronary OCT images include classification, object detection, and segmentation. Classification can be performed framewise or on individual A-lines and is typically used in a binary fashion (i.e. presence or absence of the feature of interest) or with multiple classes (e.g. lipidic plaque, calcified plaque, fibrous plaque, etc.). Object detection refers to the task of localizing a feature of interest, and is typically performed with bounding boxes (dashed lines) or a centroid (blue dot). Semantic segmentation refers to pixel-wise labelling of the feature(s) of interest. Quantification is frequently performed using post-processing steps after semantic segmentation or A-line classification and includes for example measurements of plaque components. Middle panel: Among all identified models, the overall performances (reported as medians with minimum and maximum values) for lumen and stent assessment were excellent, while plaque analysis showed varied results. Right panel: The bias signalling questionnaire, containing several questions related to data management, model development, and validation, revealed potential caveats in model training and evaluation that should be addressed in future studies.
Figure 1
Figure 1
Flowchart of study selection.
Figure 2
Figure 2
Annual publications on machine learning and deep learning.
Figure 3
Figure 3
Examples of intracoronary optical coherence tomography images in polar and Cartesian views. The top row presents three optical coherence tomography frames in polar view, while the reconstructed Cartesian view is displayed in the bottom row. (A) Polar and Cartesian view of the same frame illustrating the y-axis aligning with radius (r) and the x-axis corresponding to the angle (Θ). Corresponding A-lines are denoted by an asterisk. (B) Example of an optical coherence tomography frame with a lipidic plaque with a thick fibrous cap (arrows). The inner boundary of the lipidic plaque is outlined with a continuous line, while the estimated outer boundary is represented by a dashed line. (C) Example of an optical coherence tomography frame with a calcified plaque (white outline).
Figure 4
Figure 4
Distribution of tasks per class. Cumulative number of identified tasks for segmentation, classification, object detection, and regression over time (A–C) and per class (D). Quantification is not an artificial intelligence task but refers to transforming the model output into numerical variables to quantify for example plaque volume or fractional flow reserve.
Figure 5
Figure 5
Results of bias signalling questions.
Figure 6
Figure 6
Examples of artificial intelligence algorithms for different tasks. (A) Multiclass semantic segmentation model proposed by Chu et al. The raw optical coherence tomography image is presented in the left image, the reference standard in the middle image, and the model prediction in the right image. White represents calcium, green represents intima/fibrous, yellow represents lipid, and purple represents guidewire artefact. Used with permission of EuroIntervention, from Artificial intelligence and optical coherence tomography for the automatic characterization of human atherosclerotic plaques, Chu, 17, 1, 2021; permission conveyed through Copyright Clearance Center, Inc. (B) Detection model for the localization of metal stent struts using centroids proposed by Yang et al. Adapted with permission from Yang et al. © Optica Publishing Group. (C) Framewise classification for the presence vs. absence of thin-cap fibroatheroma proposed by Min et al. The right panel represents the gradient-weighted class activation mapping (Grad-CAM) with red colours indicating the high attended regions to predict thin-cap fibroatheroma. Used with permission of EuroIntervention, from Detection of optical coherence tomography defined thin-cap fibroatheroma in the coronary artery using deep learning, Min, 16, 5, 2020; permission conveyed through Copyright Clearance Center, Inc.

References

    1. Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, et al. Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol 2022;19:684–703. - PMC - PubMed
    1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165. - PubMed
    1. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720–3826. - PubMed
    1. Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, et al. OCT or angiography guidance for PCI in complex bifurcation lesions. N Engl J Med 2023;389:1477–1487. - PubMed
    1. Stone GW, Christiansen EH, Ali ZA, Andreasen LN, Maehara A, Ahmad Y, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet 2024;403:824–837. - PubMed

LinkOut - more resources